FDA Import Refusal SCS-2845420-2/10002/1 — Eli Lilly And Company
The FDA refused shipment SCS-2845420-2/10002/1 from Eli Lilly And Company (United States) on April 27, 2026. The refused product falls under Drugs and Biologics — PHARMACEUTIC NECESSITIES, N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 27, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 55RY99 PHARMACEUTIC NECESSITIES, N.E.C.
- Charges
- 75